Search

everythinglearnresearchcommunity

for

Search:↓

Melanoma risk tools need improvement, a gene mutation causes a hair disorder that might be treated by managing cell stress, a potential therapy for a skin-ear disorder involves blocking cell channels, skin wrinkling may indicate lung aging regardless of smoking, and oxidative stress might contribute to common baldness.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Amphetamine use may not cause hair loss, "geezer" traits are normal aging, not all educated older people are stereotypes, and metronidazole can rarely cause lung disease.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

In 2011, there were major scientific breakthroughs in cancer treatment, immunity, Parkinson's, virus simulation, schizophrenia, hair growth, lung cancer, and medical grafts.

Radiological findings help distinguish LAM, PLCH, and BHD to avoid invasive tests.

Chemotherapy and certain hair care practices can cause severe hair matting.

Gefitinib therapy can cause unusual hair growth on the nose.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Erlotinib can cause nonscarring hair loss and itchy skin.

Gefitinib can cause hair and eyebrow darkening.

EGFR inhibitors can cause skin issues like acne and dryness, but these can be managed without stopping treatment.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Cavity macrophages gather on organ surfaces but don't really invade or help repair the organs after injury.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Erlotinib can cause unexpected side effects like eyelash growth and scarring.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

Gefitinib can cause scalp skin issues and permanent hair loss.

A man developed skin issues from cancer medication, which improved with specific treatments.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

Folliculin helps regulate energy and nutrient sensing, impacting Birt–Hogg–Dubé syndrome.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Different enzymes are active in different parts of developing mouse organs.

The niche environment controls stem cell behavior and plasticity, which is important for tissue health and repair.

AS101 reduces hair loss from chemotherapy.